NSE: UNICHEMLAB | BSE: 506690

Expensive Performer

Download real time

709.70 43.90 (6.59%)

High volume+gain today

NSE 21 Mar, 2025 3:31 PM (IST)

4,996.7

Market Cap

Above industry Median

0.6

Beta 1Year

Very Low volatility

Capacity Expansion

Unichem Labs expands its API plant in Pithampur by 210 KL with a capex of Rs 200 crore See details

Unichem Laboratories Ltd. share price target and research reports

Name: Latest research reports of Unichem Laboratories Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Unichem Laboratories Ltd.
Rating: 5
Author: ICICI Securities Limited

Latest analyst research reports with target prices and PDF download for UNICHEMLAB, BSE:506690 Unichem Laboratories Ltd.

Unichem Laboratories Ltd.

24 May 2016

709.70

6.59%

Unichem Laboratories

Buy: Unichem Laboratories Ltd.

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Revenues grew 17.8% YoY to | 301.5 crore (I-direct estimate: | 311.1 crore) on account of 17.1% YoY growth in domestic sales to | 171.3...

Unichem Laboratories Ltd. has gained 43.69% in the last 1 Year

Unichem Laboratories Ltd.

22 Feb 2016, 12:00AM

709.70

6.59%

Unichem Labs: Management Interaction: US business to gain traction (Feb 22, 2016)

Buy: Unichem Laboratories Ltd.

Target

Karvy

Unichem has completed 6 years in US market. The company started launching few products in 2009. The year 2014-2015 (USD 24 mn) saw a near 100% growth on the back new launches.

Unichem Laboratories Ltd.'s price crossed above 50Day SMA today

Unichem Laboratories Ltd.

27 Jan 2016

709.70

6.59%

Unichem Laboratories

Buy: Unichem Laboratories Ltd.

ICICI Securities Limited

Number of FII/FPI investors increased from 50 to 56 in Dec 2024 qtr.

Unichem Laboratories Ltd.

27 Jan 2016

709.70

6.59%

Unichem Labs: Q3FY16 Result Review Progress Continues (Jan 27, 2016)

Buy: Unichem Laboratories Ltd.

Recommendation Target

Karvy

Unichem's total revenues increased by 15.2% YoY to Rs 3.06 bn in Q3FY16 higher than our estimates of Rs 2.98 bn while on QoQ basis it increased marginally by 0.2%. Operating margins increased by 790bps YoY to 11.1% (lower than our estimate of 12.3%).

Unichem Laboratories Ltd. has gained 43.69% in the last 1 Year

Unichem Laboratories Ltd.

19 Oct 2015

709.70

6.59%

Unichem Labs - 2QFY16 Result Update

Buy: Unichem Laboratories Ltd.

Reliance Securities

Tepid quarter; Expect better traction in 2HFY16E Unichem's 2QFY16 result is a dampener as it continues to overcome the growth challenges in export formulations (up 14.5% yoy). It missed our numbers by 7%/29%/39% for sales, margins and APAT, respectively. While the sustained growth in India formulations (up 13.2% yoy) is a relief, operating performance (at 10.7% - down 30 bps yoy and 190bps qoq) succumbed due to poor product mix. Traction in the US business (up 43% yoy in 1HFY16) partially offset the losses in the UK subsidiary. We assess that ramp up in the US will boost export growth, while...

Unichem Laboratories Ltd.'s price crossed above 30Day SMA today

Unichem Laboratories Ltd.

14 Jul 2015

709.70

6.59%

Unichem Labs: Q1FY16 Result Review-Margins Outperform (Jul 14, 2015)

Hold: Unichem Laboratories Ltd.

Karvy

Unichem's total revenues increased by 6.2% YoY to Rs 3.09 bn in Q1FY16 lower than our estimates of Rs 3.16 bn. Operating margins declined by 120bps to 13.8% (higher than our estimate of 11.7%). Better gross margins and lower other expenses contributed to better operating margins. Net Profit de-grew by 4.7% YoY to Rs 288 mn as against our estimates of Rs 244 mn.

Unichem Laboratories Ltd.'s price crossed above 30Day SMA today

No results found

Is Unichem Laboratories Ltd. worth buying?

100 Votes:

Buy 80.0%

Sell 9.0%

Hold 11.0%